ArticleAnnals of neurology2022

Severe Acute Respiratory Syndrome Coronavirus 2 Third Vaccine Immune Response in Multiple Sclerosis Patients Treated with Ocrelizumab.

Livnat Brill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.